Breast Cancer Care: Supporting ADC Therapy Through Proactive Monitoring - Part 1

Breast Cancer
Breast Cancer Care: Supporting ADC Therapy Through Proactive Monitoring

Watch Video Download Infographic

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam blandit odio leo, sed scelerisque ex accumsan nec. Quisque ut risus eros. Maecenas non tortor accumsan, commodo arcu non, consequat arcu. Ut sit amet mi ut velit sagittis semper sed a eros. Duis eget nibh sem. Nunc quis lacus dictum, euismod eros eget, accumsan erat. Aliquam a pharetra lectus. Quisque viverra, nibh quis rutrum volutpat, diam elit malesuada leo, id facilisis turpis neque ac urna.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam blandit odio leo, sed scelerisque ex accumsan nec. Quisque ut risus eros. Maecenas non tortor accumsan, commodo arcu non, consequat arcu. Ut sit amet mi ut velit sagittis semper sed a eros. Duis eget nibh sem. Nunc quis lacus dictum, euismod eros eget, accumsan erat. Aliquam a pharetra lectus. Quisque viverra, nibh quis rutrum volutpat, diam elit malesuada leo, id facilisis turpis neque ac urna.


Breast Cancer Care: Supporting ADC Therapy Through Proactive Monitoring - Part 1

Related Items

Navigating the Complex Pathways to Clinical Trial Participation
By Jennifer Flores, MS; Marcela Orozco; Kelsey Hampton, PhD
Breast Cancer
May 2026 Vol 17, No 3
Clinical trials hold the promise of groundbreaking treatments, but the pathways to participation can be daunting. Learn how navigators are empowering patients to overcome barriers, ask the right questions, and confidently explore life-changing opportunities.
Supporting Young Patients With Breast Cancer
By Zeena Nackerdien, PhD
Breast Cancer
December 2025 Vol 16, No 12
Explore the unique challenges faced by young patients with breast cancer and learn how innovative navigation programs are bridging gaps in care and empowering patients to thrive.
Identification and Treatment of Patients With Hormone Receptor–Positive, HER2-Negative Early Breast Cancer at High Risk of Recurrence: monarchE Study Long-Term Outcomes
Clinical Trials, HR+/HER2− Breast Cancer, Breast Cancer
Special Issues and Supplements
We are pleased to announce the release of our next issue of Clinical Trials to Clinical Practice. This article provides expert commentary from Joyce A. O’Shaughnessy, MD, on the use of endocrine therapy with or without adjuvant abemaciclib for patients with high-risk, hormone receptor (HR)-positive, HER2-negative early breast cancer.
Journal of Oncology Navigation & Survivorship

Contact Us | Editorial Board

Amplity

© Amplity, Inc. All rights reserved.

Connect with Us

 
 
JONS

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
    Profession or Role
    Primary Specialty or Disease State
    Country

Back to Top

Amplity © Amplity, Inc. All rights reserved.